Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R2LY
|
|||
| Former ID |
DIB009850
|
|||
| Drug Name |
Multipeptide vaccine combination
|
|||
| Synonyms |
Multipeptide vaccine combination (melanoma); Multipeptide vaccine combination (melanoma), Ludwig; MAGE-10.A2+ Melan-A ELA + NY-ESO-1b + tyrosinase + GM-CSF multipeptide vaccine (melanoma), Ludwig; MAGE-10.A2 + Melan-A ELA + NY-ESO-1b + tyrosinase + GM-CSF multipeptide vaccine (melanoma), Ludwig/Columbia
Click to Show/Hide
|
|||
| Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 1 | [1] | |
| Company |
Ludwig Institute for Cancer Research
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Journal of Clinical Oncology, 2005 ASCO Annual Meeting Proceedings. Vol 23, No 16S (June 1 Supplement), 2005: 7551. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.